- 米国企業
- Addex Therapeutics Ltd.
Addex Therapeutics Ltd.ADXN
時価総額
PER
| 2019年 12月31日 | 2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 | |
| Revenue from contract with customer | - | 4 | 3 | 1 |
| Other income | - | 266,324 | 236,997 | 22,521 |
| Research and development | - | 10 | 13 | 15 |
| General and administration | - | 6 | 6 | 7 |
| Total operating costs | - | 16 | 19 | 22 |
| Operating loss | - | -12,243,274 | -15,505,917 | -20,520,207 |
| Finance income | - | 35,304 | 217,015 | 29,251 |
| Finance expense | - | 650,629 | 63,012 | 313,257 |
| Finance result, net | - | -615,325 | 154,003 | -0 |
| Net loss before tax | - | -12,858,599 | -15,351,914 | -20,804,213 |
| Income tax expense | - | - | - | - |
| Net loss for the year | -14,780,604 | -12,858,599 | -15,351,914 | -20,804,213 |
| Basic earnings (loss) per share | - | - | -0.45 | -0.46 |
| Diluted earnings (loss) per share | - | - | -0.45 | -0.46 |
| Remeasurements of retirement benefits obligation | -745,855 | -233,529 | 260,548 | 1 |
| Exchange difference on translation of foreign operations | -838 | -4,069 | -295 | -345 |
| Other comprehensive income/(loss) for the year, net of tax | -746,693 | -237,598 | 260,253 | 1 |
| Total comprehensive loss for the year | -15,527,297 | -13,096,197 | -15,091,661 | -19,534,426 |